Pharmaceutical Business review

Pulmo BioTech’s subsidiary completes bio-distribution studies

The in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention in the liver and heart.

Further bio-distribution studies have also shown that after 240 minutes the majority of the injected molecules have been eliminated through the kidneys and bladder.